Le Lézard
Classified in: Science and technology
Subject: Merger/Acquisition

Carenet Completes Acquisition of Health Dialog Assets from Rite Aid


Carenet Health, a trusted partner in transforming the business of healthcare, finalized today its acquisition of clinical support staff and leading technology assets from Health Dialog.

Health plans and health systems will benefit from additional tech-enabled customer experience solutions that emphasize the importance of value-based care, focusing significantly on chronic care management and shared decision-making.

"This acquisition bolsters our already strong AI and machine learning capabilities to further help our 500+ leading healthcare groups evolve their business to meet consumer demands for personalized, forward-thinking care," said John Erwin, Carenet chief executive officer. "With our combined technology platforms, we can continue leveraging our deep data-driven insights to power more seamless engagement experiences for patients and members."

The Health Dialog Pathways Engine predictive analytics and machine learning platform uses 600+ health data points to identify long-term disease trajectory for members, including conditions like asthma, diabetes and heart disease. The tool enables a whole-person, long-term view of an individual's healthcare journey and synchronizes all communications and channels to ensure the best outcomes for clients and consumers. This includes bespoke clinical interventions and action plans to address an individual's unique needs, while also building proactive strategies to delay progression into higher cost stages.

With these added shared decision-making capabilities, Carenet will help clients empower patients with multiple viable treatment options to manage their care and collaborate with their physicians on treatment, while driving measurable cost savings for payers and providers.

This is the latest in a series of strategic acquisitions from Carenet, supplying more integrated, proven solutions for clients looking to streamline their vendor relationships. Health Dialog joins brands such as Inquicker, Beryl Health, Patient Prompt and Academic Health Network as just a sampling of the cutting-edge capabilities Carenet has combined under its robust set of service offerings.

Both Carenet and Health Dialog hold accreditations from the National Committee for Quality Assurance (NCQA) and URAC.

About Carenet

Carenet Health is committed to delivering the business of healthcare through cutting-edge technology, unmatched insights and operational excellence to help payers, providers and health service organizations better meet consumer healthcare needs. For more than 25 years, we have delivered unmatched perspectives to help healthcare companies around the globe solve complex business challenges faster while delivering best-in-class engagement outcomes for consumers. Learn more at www.carenethealth.com.


These press releases may also interest you

at 21:00
Full Sail University's Annual Hall of Fame week kicked off with "Hall of Game." This esports event welcomed students and alumni to compete in popular titles including Call of Duty, Rocket League, and Super Smash Bros. Through Full Sail's partnership...

at 21:00
TIER IV, a pioneer in developing open-source software for autonomous driving (AD) systems, is set to launch a unique robotaxi service in November 2024. Initially targeting areas and times that conventional taxi operators struggle to serve, the...

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...



News published on and distributed by: